Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis with Vasopressor-dependent Shock: A Propensity-Score Matched Analysis from 130 US Hospitals
Author(s) -
Sameer S. Kadri,
Bruce Swihart,
Stephanie Bonne,
Samuel F. Hohmann,
Laura Hennessy,
Peter Louras,
Heather L. Evans,
Chanu Rhee,
Anthony F. Suffredini,
David C. Hooper,
Dean Follmann,
Eileen M. Bulger,
Robert L. Danner
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciw871
Subject(s) - medicine , fasciitis , propensity score matching , toxic shock syndrome , odds ratio , confidence interval , shock (circulatory) , comorbidity , staphylococcus aureus , surgery , biology , bacteria , genetics
Shock frequently complicates necrotizing fasciitis (NF) caused by group A Streptococcus (GAS) or Staphylococcus aureus. Intravenous immunoglobulin (IVIG) is sometimes administered for presumptive toxic shock syndrome (TSS), but its frequency of use and efficacy are unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom